![]() |
市场调查报告书
商品编码
1885874
菌丝体蛋白配料市场机会、成长驱动因素、产业趋势分析及预测(2025-2034年)Mycelium-Based Protein Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球菌丝体蛋白配料市场价值为 4.25 亿美元,预计到 2034 年将以 19.6% 的复合年增长率增长至 28 亿美元。

消费者对环保蛋白质来源的需求不断增长,持续推动着这一领域的扩张,越来越多的人寻求营养丰富且可持续的替代品。这种日益增长的兴趣促使零售商和餐饮服务公司推出更多种类的真菌衍生产品,从而加快了替代蛋白领域的产品开发速度,并扩大了生产能力。发酵科学和生物製程工程的进步正推动生产向大规模化方向发展,而工业生物反应器的设计旨在实现更高的控制精度、更高的产量和更稳定的品质。从试点营运到商业规模生产的转变,得益于资金投入的增加和对新生产基地的大量投资,从而提高了食品製造商可获得的菌丝体原料的供应量。来自公共和私营部门的财政支持正在加速工厂建设,并推动整个供应链的快速扩张。正如生产商和采购商所证实的那样,资金的涌入缩短了商业化进程,透过规模效益降低了成本,并扩大了整体市场容量。
| 市场范围 | |
|---|---|
| 起始年份 | 2024 |
| 预测年份 | 2025-2034 |
| 起始值 | 4.25亿美元 |
| 预测值 | 28亿美元 |
| 复合年增长率 | 19.6% |
受全食品应用和清洁标籤偏好的推动,新鲜和冷冻菌丝体生物质市场预计在2024年达到2.401亿美元。其天然的质地和丰富的膳食纤维使其无需深度加工即可製成整块替代品、肉饼或即食食品。这种产品形式非常适合那些希望缩短成分錶、减少生产步骤、实现规模化生产并更快进入零售和餐饮通路的品牌。
2024年,液态发酵市场规模达3.404亿美元,凭藉其高效性和可扩展性,仍是主要的生产方式。该技术利用大型工业生物反应器,能够精确监控温度、氧气、营养液流量和pH值,从而支持生物质的持续成长和更可预测的产量。改进的製程控制提高了生产效率,而成本效益使其适用于为大型食品製造商和快餐企业供货的公司。
2024年,北美菌丝体蛋白配料市占率将达到36.4%,其中美国市场表现强劲。该地区受益于成熟的发酵设施、经验丰富的配套设施以及对真菌蛋白研发企业的早期投资。大量的创投加速了产能扩张,并支持了零售和餐饮服务业的快速商业化。消费者对高蛋白、清洁标章和环保产品的日益关注,也推动了零售商对菌丝体产品的需求,从而促进了产品多元化。
菌丝体蛋白配料市场的主要企业包括Maia Farms、My Forest Foods、Meati Foods、Bosque Foods、Optimized Foods、Cargill、Planetary、Better Meat Co.和Esencia Foods。这些企业运用多种策略来提升自身的竞争力。许多企业专注于扩大发酵产能和优化生物工艺,以提高产量并降低生产成本。研发投入有助于企业改善产品的质地、风味和营养成分,从而满足食品生产商和消费者的期望。与零售商、配料供应商和餐饮服务业者建立策略合作伙伴关係,可拓展分销网络,并加速市场整合。此外,各品牌也强调清洁标籤定位和永续发展概念,以增强消费者信任。
The Global Mycelium-Based Protein Ingredients Market was valued at USD 425 million in 2024 and is estimated to grow at a CAGR of 19.6% to reach USD 2.8 billion by 2034.

Rising consumer demand for environmentally conscious protein sources continues to help in this expansion, as more individuals seek nutrient-dense, sustainable alternatives. This growing interest has encouraged retailers and foodservice companies to introduce a wider range of fungi-derived offerings, prompting faster product development and broader manufacturing capabilities across the alternative-protein landscape. Advancements in fermentation science and bioprocess engineering are pushing production toward large-scale capabilities, supported by industrial bioreactors designed to deliver greater control, higher yields, and consistent quality. The shift from pilot operations to commercial-scale facilities is reinforced by increased funding activities and significant investments in new production sites, boosting the availability of mycelium ingredients for food manufacturers. Financial support from both private and public sectors is accelerating the construction of factories and driving rapid expansion across the supply chain. This surge in capital flow shortens commercialization timelines, reduces costs through scale efficiencies, and expands overall market capacity as documented by producers and purchasers.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $425 Million |
| Forecast Value | $2.8 Billion |
| CAGR | 19.6% |
The fresh and frozen mycelium biomass segment reached USD 240.1 million in 2024, driven by alignment with whole-food applications and clean-label preferences. Its natural texture and fiber-rich profile allow producers to create whole-cut alternatives, patties, or ready-made meals without heavy processing. This format is ideal for brands looking for shorter ingredient lists, reduced production steps, scalable volume, and quicker entry into retail and foodservice channels.
The submerged fermentation segment was valued at USD 340.4 million in 2024 and continues to serve as the primary production method due to its efficiency and scalability. This technique leverages large industrial bioreactors that allow precise monitoring of temperature, oxygen, nutrient flow, and pH, supporting continuous biomass growth and more predictable output. Improved process control results in higher productivity, while cost efficiencies make it suitable for companies supplying large food manufacturers and quick-service businesses.
North America Mycelium-Based Protein Ingredients Market held a 36.4% share in 2024, led by strong activity in the United States. The region benefits from established fermentation facilities, experienced infrastructure, and early investments in companies developing fungal proteins. Substantial venture funding accelerates capacity growth and supports rapid commercialization in both retail and foodservice sectors. Rising consumer interest in high-protein, clean-label, and environmentally friendly options strengthens the demand for mycelium-based products as retailers seek to diversify their product offerings.
Major companies active in the Mycelium-Based Protein Ingredients Market include Maia Farms, My Forest Foods, Meati Foods, Bosque Foods, Optimized Foods, Cargill, Planetary, Better Meat Co., and Esencia Foods. Companies in the Mycelium-Based Protein Ingredients Market use multiple strategies to enhance their competitive position. Many focus on expanding fermentation capacity and optimizing bioprocesses to increase output while lowering production costs. Investments in R&D help firms improve texture, flavor, and nutritional profiles to meet the expectations of food manufacturers and consumers. Strategic partnerships with retailers, ingredient suppliers, and foodservice operators expand distribution networks and support quicker market integration. Brands also emphasize clean-label positioning and sustainability messaging to strengthen consumer trust.